YS 1.07 YS Biopharma Co., Ltd.
| Range: | 0.3503-1.78 | Vol Avg: | 130559 | Last Div: | 0 | Changes: | 0.09 |
| Beta: | 0.54 | Cap: | 0.19B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Aug 05 2021 | Empoloyees: | 773 | ||
| CUSIP: | CIK: | 0001946399 | ISIN: | KYG9845F1090 | Country: | CN | |
| CEO: | Dr. Hui Shao C.F.A., M.B.A., Ph.D. | Website: | https://www.yishengbio.com | ||||
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow